NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
9.19
+0.01 (0.11%)
Nov 20, 2024, 4:00 PM EST - Market closed
NeuroPace Revenue
NeuroPace had revenue of $21.06M in the quarter ending September 30, 2024, with 28.20% growth. This brings the company's revenue in the last twelve months to $76.45M, up 27.00% year-over-year. In the year 2023, NeuroPace had annual revenue of $65.42M with 43.72% growth.
Revenue (ttm)
$76.45M
Revenue Growth
+27.00%
P/S Ratio
3.41
Revenue / Employee
$447,088
Employees
171
Market Cap
274.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 65.42M | 19.90M | 43.72% |
Dec 31, 2022 | 45.52M | 337.00K | 0.75% |
Dec 31, 2021 | 45.18M | 4.05M | 9.83% |
Dec 31, 2020 | 41.14M | 4.17M | 11.27% |
Dec 31, 2019 | 36.97M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accolade | 441.03M |
AngioDynamics | 292.73M |
Poseida Therapeutics | 150.86M |
Lifecore Biomedical | 128.44M |
Mersana Therapeutics | 34.84M |
Eton Pharmaceuticals | 34.68M |
Artiva Biotherapeutics | 2.60M |
NPCE News
- 8 days ago - NeuroPace, Inc. (NPCE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy - GlobeNewsWire
- 4 weeks ago - NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 5 weeks ago - NeuroPace Continues to Strengthen Management Team - GlobeNewsWire
- 2 months ago - NeuroPace Strengthens Management Team with Two Key Appointments - GlobeNewsWire
- 3 months ago - NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 3 months ago - NeuroPace to Participate in Upcoming Healthcare Conferences in September - GlobeNewsWire
- 3 months ago - NeuroPace: Only For Those With Strong Nerves - Seeking Alpha